On February 19, 2026, Scilex Holding Company entered into a Warrant Agreement with Oramed Pharmaceuticals Inc., allowing Oramed to defer a payment in exchange for warrants to purchase 100,000 shares of common stock at $20.00 each. This filing is significant as it affects the company's capital structure and financial obligations.